LONDON--Vectura Group PLC (VEC.LN), a developer of therapies for the treatment of airways-related diseases, on Thursday announced that its alliance partner Novartis, has confirmed that Pfizer Limited has signed an exclusive agreement to commercialize Ultibro Breezhaler and Seebri Breezhaler in the United Kingdom.

Shares closed Wednesday at 135.25 pence.

-Write to Jana Simmons at jana.simmons@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Pfizer Charts.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Pfizer Charts.